1. Antinore, M. J., Birrer, M. J., Patel, D., Nader, L. & McCance, D. J. (1996). The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factor. EMBO J 15: 1950–1960.
2. Atkin, N. B., Baker, M. C. & Fox, M. F. (1989). Chromosome changes in 43 carcinomas of the cervix uteri. Cancer Genet Cytogenet 44: 229–241.
3. Banks, L., Edmonds, C. & Vousden, K. H. (1995). Ability of the HPV16 E7 protein to bind Rb and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells. Oncogene 5: 1383–1389.
4. Bartholomew, I. S., Glenville, S., Sarkar, S., Burt, D. J., Stanley, M. A., Ruiz-Cabello, F., Chengang, J., Garrido, F. & Stern, P. L. (1997). Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I antigens by steroid hormones in cervical tumor cells. Cancer Res 57: 937–942.
5. Bartsch, D., Boye, B., Baust, C., zur Hausen, H. & Schwarz, E. (1992). Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J 11: 2283–2291.